98%
921
2 minutes
20
Objective: Measuring facial muscle activity is crucial in the diagnosis of facial palsy. This study investigated whether contactless Magnetomyography (MMG) using optically pumped magnetometers (OPM) is feasible for visualizing facial muscle activity.
Methods: An anatomically shaped mask featuring eleven OPM was arranged on one side of the face of five healthy subjects. MMG was recorded while they performed different facial expressions. The root mean square of each OPM signal was calculated for each expression and subject and allocated to the individual face. Moreover, the maximum average muscle activity and the signal-to-noise ratio (SNR) were determined.
Results: The subjects' facial muscle activity could be measured individually per facial expression. Mean RMS was 0.6pT (SD 0.4pT), resulting in a mean SNR of 2.2 (SD 1.2).
Conclusions: Imaging facial activity via MMG using OPM is possible, although the sensor positioning (sensor geometry and distance to the muscle) is decisive. However, the signal amplitude of the facial muscles is low and the interindividual anatomical variability renders the measurement setup challenging.
Significance: As the imaging of facial MMG is feasible, this study paves the way for future studies using OPM for the diagnosis, monitoring, and rehabilitation of facial muscle and facial nerve disorders.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11999314 | PMC |
http://dx.doi.org/10.1016/j.cnp.2025.03.003 | DOI Listing |
J Mater Chem B
September 2025
Nebraska Translational Research Center (NTRC), Department of Growth and Development, College of Dentistry, University of Nebraska Medical Center, Joseph D. & Millie E. Williams Science Hall, 525 S 42nd St, Room No 3.0.010, Omaha, NE 68105-6040, USA.
Facial nerve injuries cause significant functional impairments, affect facial expressions, speech, and overall quality of life. This article explores advances in facial nerve regeneration, encompassing both conventional and emerging therapeutic strategies. The regenerative process involves Wallerian degeneration, axonal regrowth, and target muscle reinnervation, where the distal axon degrades and the proximal axon initiates sprouting to restore connectivity.
View Article and Find Full Text PDFPsychophysiology
September 2025
Department of Psychology, Clinical Psychology and Psychotherapy, University of Regensburg, Regensburg, Germany.
Facial emotional expressions are interactive signals that communicate intentions. Previous research has shown that sending a facial emotional expression influences the evaluation of response expressions, but the mechanisms behind this effect remain unclear. In a preregistered experiment, 68 participants were asked to send an emoji (happy, neutral, and angry) to a virtual agent in front of them, whereupon the agent reacted with either a smiling or frowning facial expression.
View Article and Find Full Text PDFJ Oral Rehabil
September 2025
Division of Functional Oral Neuro Science, Graduate School of Dentistry, The University of Osaka, Osaka, Japan.
Background: Older adults have decreased swallowing-related muscle mass, which may lead to decreased swallowing function. One of the causes of this decrease in muscle mass in older adults is a decrease in swallowing frequency.
Objective: The purpose of this study was to evaluate the relationship between swallowing frequency and swallowing-related muscle mass.
Laryngoscope
September 2025
Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology/Head and Neck Surgery, University of North Carolina, North Carolina, USA.
The choice of a donor nerve to innervate a free gracilis muscle transfer (FMGT) is more complicated in patients with a history of previous facial paralysis surgeries. This case report describes the use of the deep temporal nerve to successfully power a FMGT in a nerve-depleted patient.
View Article and Find Full Text PDFBrain Behav
September 2025
Department of Neurology, Huai'an First People's Hospital, the Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Background And Purpose: Parkinson's disease (PD), a prevalent neurodegenerative disorder characterized by motor impairments, frequently accompanied by neuropsychiatric symptoms that significantly impair daily functioning and quality of life. The present study aimed to assess the efficacy of botulinum toxin A (BTX-A) in alleviating neuropsychiatric symptoms among PD patients.
Methods: This is an open-label, nonrandomized controlled trial.